Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | BCL2 | P10415 | 1/20 | 0.37 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2029483 | 0.88 | PPARG (0.44) | ALOX5ALDH1A1CYP3A4ARPTGS1 | |
| SCHEMBL2843447 | 0.84 | ALOX5 (0.46) | ALOX5ALDH1A1CYP3A4ARPTGS1 | |
| SCHEMBL7948321 | 0.82 | BCL2 (0.41) | ALOX5CYP3A4BCL2BCL2L1 | |
| SCHEMBL11876989 | 0.81 | GABRA1 (0.42) | ALOX5ALDH1A1CYP3A4GABRA1GABRB2 | |
| SCHEMBL1173287 | 0.81 | ALOX5 (0.44) | ALOX5ALDH1A1CYP3A4ARPTGS1 | |
| Salicylic Acid SCHEMBL11345117 | 0.80 | CYP2C9 (0.45) | ALOX5ALDH1A1CYP3A4ARGABRA1 | |
| SCHEMBL2030041 | 0.78 | PDE4B (0.47) | ALOX5ALDH1A1CYP3A4ARPTGS1 | |
| SCHEMBL11553229 | 0.78 | ALOX5 (0.42) | ALOX5ALDH1A1CYP3A4ARPTGS1 | |
| SCHEMBL28069115 | 0.78 | TRPM8 (0.42) | ALOX5ALDH1A1CYP3A4ARPTGS1 | |
| SCHEMBL29101603 | 0.77 | ALOX5 (0.41) | ALOX5ALDH1A1CYP3A4ARPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| EP-1894603-B1 | Encapsulation of bulky fragrance molecules | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| US-8609600-B2 | Encapsulation of bulky fragrance molecules | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-12-17 | — | — | US | claimed |
| JP-63167791-A | — | — | None | — | — | JP | disclosed |
| US-20240408090-A1 | Methods Of Treating Dyskinesia And Related Disorders | MELIOR PHARMACEUTICALS II, LLC | 2024-12-12 | — | — | US | disclosed |
| US-12048697-B2 | Methods of treating dyskinesia and related disorders | MELIOR PHARMACEUTICALS II, LLC (US) | 2024-07-30 | — | — | US | disclosed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | disclosed |
| US-20220331320-A1 | Methods Of Treating Dyskinesia And Related Disorders | MELIOR PHARMACEUTICALS II, LLC | 2022-10-20 | — | — | US | disclosed |
| US-11351169-B2 | Methods of treating dyskinesia and related disorders | MELIOR PHARMACEUTICALS II, LLC (US) | 2022-06-07 | — | — | US | disclosed |
| CN-108699493-B | Detergent composition | 狮王株式会社 | 2021-10-08 | — | — | CN | disclosed |
| CN-111944609-A | Perfume composition with plum blossom fragrance | 北京林业大学 | 2020-11-17 | — | — | CN | disclosed |
| EP-1894603-A1 | Encapsulation of bulky fragrance molecules | Takasago International Corporation (JP) | 2008-03-05 | — | — | EP | disclosed |
| EP-1827370-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | Showa Denko K.K. (JP) | 2007-09-05 | — | — | EP | disclosed |
| EP-1765139-A1 | ROLLER FOR PROVIDING BENEFITS TO FABRIC | The Procter and Gamble Company (US) | 2007-03-28 | — | — | EP | disclosed |
| US-20060165622-A1 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-07-27 | — | — | US | disclosed |
| WO-2006068276-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | SHOWA DENKO K.K. (JP) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006010087-A1 | ROLLER FOR PROVIDING BENEFITS TO FABRIC | THE PROCTER & GAMBLE COMPANY (US) | 2006-01-26 | — | — | WO | disclosed |
| US-20060005333-A1 | Roller for providing benefits to fabric | PROCTER & GAMBLE COMPANY, THE | 2006-01-12 | — | — | US | disclosed |
| EP-1561476-A1 | DEODORANT COMPOSITION | Takasago International Corporation (JP) | 2005-08-10 | — | — | EP | disclosed |
| JP-S63167791-A | MUTATION INHIBITOR | KANEBO LTD | 1988-07-11 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220331320-A1 | Methods Of Treating Dyskinesia And Related Disorders | SLC6A3, CHAT, ACHE | ALOX5 1729/4885ALDH1A1 1203/4885CYP3A4 2524/4885 |
| US-20240408090-A1 | Methods Of Treating Dyskinesia And Related Disorders | SLC6A3, CHAT, ACHE | ALOX5 1729/4885ALDH1A1 1203/4885CYP3A4 2524/4885 |
| US-12048697-B2 | Methods of treating dyskinesia and related disorders | SLC6A3, CHAT, ACHE | ALOX5 1729/4885ALDH1A1 1203/4885CYP3A4 2524/4885 |
| US-11351169-B2 | Methods of treating dyskinesia and related disorders | SLC6A3, CHAT, ACHE | ALOX5 1729/4885ALDH1A1 1203/4885CYP3A4 2524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.